Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Pan Cardiomyopathy Panel (62 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 100 | 61 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Ambry Genetics United States | 58 | 30 |
|
Ambry Genetics United States | 58 | 30 |
|
Ambry Genetics United States | 236 | 167 |
|
Ambry Genetics United States | 138 | 56 |
|
Ambry Genetics United States | 189 | 92 |
|
PreventionGenetics, part of Exact Sciences United States | 112 | 111 |
|
Hypertrophic Cardiomyopathy Panel PreventionGenetics, part of Exact Sciences United States | 67 | 64 |
|
PreventionGenetics, part of Exact Sciences United States | 64 | 49 |
|
Comprehensive Cardiology Panel PreventionGenetics, part of Exact Sciences United States | 224 | 202 |
|
Invitae Hypertrophic Cardiomyopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 75 | 59 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Cardiomyopathy, familial hypertrophic 17 (sequence analysis of JPH2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Hypertrophic Cardiomyopathy Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 25 | 34 |
|
Arrhythmia & Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 211 | 93 |
|
Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 170 | 71 |
|
Cardiomyopathy, familial hypertrophic: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 30 | 26 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.